Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Restructuring Costs: 2009-2024

Historic Restructuring Costs for Sunshine Biopharma (SBFM) over the last 3 years, with Dec 2024 value amounting to $3.1 million.

  • Sunshine Biopharma's Restructuring Costs rose 15.90% to $614,661 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 13.15%. This contributed to the annual value of $3.1 million for FY2024, which is 45.17% up from last year.
  • Sunshine Biopharma's Restructuring Costs amounted to $3.1 million in FY2024, which was up 45.17% from $2.1 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Restructuring Costs registered a high of $3.1 million during FY2024, and its lowest value of $2.1 million during FY2023.
  • Moreover, its 2-year median value for Restructuring Costs was $2.6 million (2023), whereas its average is $2.6 million.
  • Data for Sunshine Biopharma's Restructuring Costs shows a peak YoY surged of 45.17% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Sunshine Biopharma's Restructuring Costs stood at $2.1 million in 2023, then spiked by 45.17% to $3.1 million in 2024.